Vaccines

The risk for herpes zoster is known to increase with age. Previous evidence has indicated that the herpes zoster recombinant subunit vaccine is highly effective in preventing the virus in adults age 50...

To help improve HBV care, the American College of Physicians and Centers for Disease Control and Prevention have developed new best practice guidance for hepatitis B vaccination and screening.

In a recent study, researchers investigated the safety and immunogenicity of norovirus vaccine candidate formulations among health adults.

In a recent study, researchers evaluated the effectiveness of the influenza vaccine over the course of 4 influenza seasons through 2014.

The US Food and Drug Administration has approved the first new vaccine for hepatitis B virus in over 25 years in the United States.

In a recent study, researchers sought to determine whether a web-based social media intervention could improve early childhood immunization rates.

The risk for herpes zoster is increased in patients with rheumatoid arthritis. In a recent study, researchers assessed the safety and efficacy of administering the live zoster vaccine in patients age 50...

In a recent study, researchers aimed to establish the non-inferiority of co-administration of the inactivated quadrivalent influenza vaccine and the 23-valent pneumococcal polysaccharide vaccine vs separate...

Seasonal influenza vaccines are transitioning to quadrivalent formulations. In a new study, researchers compared the safety and efficacy of the quadrivalent recombinant influenza vaccine and the...

Respiratory syncytial virus is a known cause of illness among older adults. In a recent study, researchers tested the safety and efficacy of the adjuvanted, postfusion F protein-based vaccine for...